Parapsorjasi (Parapsoriasis) tirreferi għal waħda minn grupp ta' disturbi fil-ġilda li huma kkaratterizzati primarjament mix-xebh tagħhom mal-psoriasi (psoriasis) (leżjonijiet ħomor, qxur). Il-parapsorjasi hija dermatosi limfoproliferattiva tal-ġilda rari li sseħħ prinċipalment f'adulti ta' età medja, li 2/3 minnhom huma rġiel.
Il-kanċer tal-ġilda jista' jiġi żviluppat minn parapsorjasi (parapsoriasis). Pereżempju, jista 'jiżviluppa f'limfoma taċ-ċelluli T tal-ġilda.
○ Djanjosi u Trattament Testijiet tad-demm biex jeskludu s-sifilide Bijopsija biex teskludi limfomi tal-ġilda
Parapsoriasis refers to one of a group of skin disorders that are characterized primarily by their resemblance to psoriasis (red, scaly lesions), rather than by their underlying cause.
Parapsoriasis is an uncommon inflammatory skin disease characterized by chronic patches that may be resistant to therapy. It was primarily introduced and classified 120 years ago, and the original classification incorporated parapsoriasis and pityriasis lichenoides under the umbrella term parapsoriasis. After a major change in classification, parapsoriasis now exclusively refers to small plaque parapsoriasis (SPP) and large plaque parapsoriasis (LPP). However, debates still frequently occur regarding various nomenclatures and classifications used by different authors. Moreover, parapsoriasis may progress to overt cutaneous lymphoma, most commonly mycosis fungoides (MF), and it is very difficult to distinguish these two conditions despite modern histologic and molecular testing techniques.
Parapsoriasis, presented as an early stage of cutaneous T-cell lymphoma, is mostly treated with psoralen and ultraviolet A (PUVA) therapy and narrowband ultraviolet B (NB-UVB) phototherapy.
Il-kanċer tal-ġilda jista' jiġi żviluppat minn parapsorjasi (parapsoriasis). Pereżempju, jista 'jiżviluppa f'limfoma taċ-ċelluli T tal-ġilda.
○ Djanjosi u Trattament
Testijiet tad-demm biex jeskludu s-sifilide
Bijopsija biex teskludi limfomi tal-ġilda